33
Views
8
CrossRef citations to date
0
Altmetric
Article

Changes in bone mineral density differ between gonadotrophin‐releasing hormone analogue‐ and surgically castrated men with prostate cancer
A prospective, controlled, parallel‐group study

, , &
Pages 148-152 | Received 08 Nov 2002, Accepted 24 Jun 2003, Published online: 09 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Francesco Bertoldo, Serena Pancheri, Sonia Zenari & Stefania Boldini. (2010) Emerging drugs for the management of cancer treatment induced bone loss. Expert Opinion on Emerging Drugs 15:2, pages 323-342.
Read now

Articles from other publishers (7)

Yu Guang Tan, Randy JY Poon, Leonard JW Pang, Andre Villanueva, Hong Hong Huang, Kenneth Chen, Tze Kiat Ng, Kae Jack Tay, Henry SS Ho & John SP Yuen. (2020) Comparative study of surgical orchidectomy and medical castration in treatment efficacy, adverse effects and cost based on a large prospective metastatic prostate cancer registry. Urologic Oncology: Seminars and Original Investigations 38:8, pages 682.e1-682.e9.
Crossref
Ippei Kojima, Yushi Naito, Akiyuki Yamamoto, Yasuhiro Terashima, Norie Sho, Jun Nagayama, Yurika Okada & Tatsuya Nagai. (2019) Efficacy of zoledronic acid in older prostate cancer patients undergoing androgen deprivation therapy. Osteoporosis and Sarcopenia 5:4, pages 128-131.
Crossref
Do Kim, Joo Lee, Kwang Kim, Namki Hong, Jong Kim, Yoon Hah, Kyo Koo, Jae Kim & Kang Cho. (2019) Effect of Androgen-Deprivation Therapy on Bone Mineral Density in Patients with Prostate Cancer: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 8:1, pages 113.
Crossref
P J Owen, R M Daly, P M Livingston & S F Fraser. (2017) Lifestyle guidelines for managing adverse effects on bone health and body composition in men treated with androgen deprivation therapy for prostate cancer: an update. Prostate Cancer and Prostatic Diseases 20:2, pages 137-145.
Crossref
K A Bolam, D A Galvão, N Spry, R U Newton & D R Taaffe. (2012) AST-induced bone loss in men with prostate cancer: exercise as a potential countermeasure. Prostate Cancer and Prostatic Diseases 15:4, pages 329-338.
Crossref
Fred SaadJonathan D. AdachiJacques P. BrownLeah A. CanningKaren A. GelmonRobert G. JosseKathleen I. Pritchard. (2008) Cancer Treatment–Induced Bone Loss in Breast and Prostate Cancer. Journal of Clinical Oncology 26:33, pages 5465-5476.
Crossref
Shabbir M.H. Alibhai, Sven Gogov & Zishan Allibhai. (2006) Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: A systematic literature review. Critical Reviews in Oncology/Hematology 60:3, pages 201-215.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.